Capabilities · Regulatory & documentation support

Post-market quality & safety interfaces

A proposed service scope for commercial product maintenance, connecting complaint handling, defect investigations, recall coordination and safety data exchange.

PlannedCatalogue scope

Illustrative unbranded bound document edge detail.
Illustrative unbranded bound document edge detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Post-market quality and safety interfaces are presented as a planned service domain. The product classification, the distribution network and the assigned legal responsibilities would determine the scope.

The initial Boten formulation-and-filling plan focuses on the physical production of batches. This proposed post-market support activity lies outside the initial plan and would require explicit scope confirmation.

Manufacturing investigations and formal pharmacovigilance are distinct technical disciplines. Inclusion in this catalogue does not establish that the facility would assume regulatory responsibility for product safety monitoring.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Product complaint investigationsTechnical review of reported quality defects, requiring batch record assessment and root-cause analysis.Catalogue scopePlanned
Safety data exchangeFormalised communication pathways for reporting adverse events or potential product safety signals.Catalogue scopePlanned
Recall coordinationPlanned administrative support for retrieving distributed material following a confirmed quality or safety issue.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Interface scope definition

Map the communication pathways between the manufacturing site, the partner and the applicable regulatory authorities.

02 · Process stage

Planned

Complaint intake procedures

Establish formal mechanisms for receiving, classifying and documenting reported post-market product quality issues.

03 · Process stage

Planned

Batch record investigation

Review the historical manufacturing and analytical data relevant to the identified post-market physical defect.

04 · Process stage

Planned

Root cause analysis

Identify the technical origin of the reported issue and determine any broader production batch impact.

05 · Process stage

Planned

Corrective action planning

Draft proposed changes to site procedures or process controls to prevent recurrence of the identified defect.

06 · Process stage

Planned

Information reporting execution

Provide the finalised technical investigation summary and requested safety data to the accountable product owner.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Returns, recalls & disposal coordination

Future lifecycle responsibilities and appropriate controls.

Explore proposed scope

02PlannedCatalogue scope

Quality & technical agreements

Responsibilities, information exchange and decision boundaries for a proposed arrangement.

Explore proposed scope

03PlannedCatalogue scope

Clinical & commercial batch programmes

Distinct batch purposes, controls and applicable permissions.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Approved reporting procedures
Documented instructions for handling product complaints, safety signals and rapid-alert authority notifications.
Retained product samples
Physical reference material from the relevant batch, available for comparative examination and analytical testing.
Complete batch records
The consolidated history of production, testing, review and disposition for the affected material.
Distribution traceability
Records identifying the first-line destinations to support potential market-action requirements and retrieval.
Quality responsibilities
Clear accountability for conducting investigations and notifying the applicable competent regulatory authorities.
Technical agreement
Agreed timelines and legal boundaries for any post-market safety and quality data exchange engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating post-market support or safety-interface service.

Would the site act as the legal product owner?

No. The proposed service would supply manufacturing investigation data to the partner. Legal accountability for product safety and market action remains separate.

What information helps define the question?

Identify the proposed product type, the intended markets, the distribution model and the anticipated reporting pathways. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, permissions, evidence and any agreement would need to be established before a post-market service commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma